deCODE Genetics files for Chapter 11

Tue Nov 17, 2009 12:30am EST

Nov 17 (Reuters) - DeCODE Genetics Inc DCGN.O, a Reykjavik, Iceland-headquartered bio-pharmaceutical company filed for Chapter 11 bankruptcy protection, court documents showed.

In a filing with the U.S. Bankruptcy Court for the District of Delaware late on Monday, deCODE listed estimated total assets in the range of $50 million to $100 million and estimated total liabilities in the range of $100 million to $500 million. (Reporting by Ajay Kamalakaran in Bangalore; Editing by Lincoln Feast)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.